Guan Hao Biotech announced at noon that it had received a warning letter from the Guangdong Securities Regulatory Bureau due to failure to promptly disclose major developments in major litigation matters and the termination of the subsidiary's exclusive distribution rights in a timely manner.
冠昊生物：收到广东证监局警示函
Guan Hao Biology: Received a warning letter from the Guangdong Securities Regulatory Bureau
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.